| Company Name: |
ChemOrigin Pharm |
| Tel: |
15026428026 19002516454 |
| Email: |
ChemOrigin@126.com |
|
| | (4R)-1-[(5-Chloro-1H-1,2,4-triazol-1-yl)methyl]-4-(3,4,5-trifluorophenyl)-2-pyrrolidinone Basic information |
| | (4R)-1-[(5-Chloro-1H-1,2,4-triazol-1-yl)methyl]-4-(3,4,5-trifluorophenyl)-2-pyrrolidinone Chemical Properties |
| Boiling point | 504.2±60.0 °C(Predicted) | | density | 1.63±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | -0.07±0.50(Predicted) | | form | Solid | | color | Off-white to light yellow |
| | (4R)-1-[(5-Chloro-1H-1,2,4-triazol-1-yl)methyl]-4-(3,4,5-trifluorophenyl)-2-pyrrolidinone Usage And Synthesis |
| Uses | SDI-118 is an orally active modulator for synaptic vesicle glycoprotein 2A (SV2A) with an IC50 of 13 nM[1]. | | References | [1] Botermans W, et al., SDI-118, a novel procognitive SV2A modulator: First-in-human randomized controlled trial including PET/fMRI assessment of target engagement. Front Pharmacol. 2023 Jan 17;13:1066447. DOI:10.3389/fphar.2022.1066447 |
| | (4R)-1-[(5-Chloro-1H-1,2,4-triazol-1-yl)methyl]-4-(3,4,5-trifluorophenyl)-2-pyrrolidinone Preparation Products And Raw materials |
|